Post-transplant diabetes mellitus in patients with solid organ transplants

T Jenssen, A Hartmann - Nature Reviews Endocrinology, 2019 - nature.com
Solid organ transplantation (SOT) is a life-saving procedure and an established treatment for
patients with end-stage organ failure. However, transplantation is also accompanied by …

Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes

V Shivaswamy, B Boerner, J Larsen - Endocrine reviews, 2016 - academic.oup.com
Post-transplant diabetes mellitus (PTDM) is a frequent consequence of solid organ
transplantation. PTDM has been associated with greater mortality and increased infections …

Common infections in kidney transplant recipients

S Karuthu, EA Blumberg - … Journal of the American Society of …, 2012 - journals.lww.com
Infections are a major cause of morbidity and mortality in kidney transplant recipients. To
some extent, these may be preventable. Careful pretransplant screening, immunization, and …

[HTML][HTML] Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus

F Vincenti, S Friman, E Scheuermann… - American Journal of …, 2007 - Elsevier
DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C 2 Monitoring Versus
Tacrolimus) was a 6-month, open-label, randomized, multicenter study which used …

New onset diabetes after transplantation (NODAT): an overview

PTT Pham, PMT Pham, SV Pham… - … syndrome and obesity …, 2011 - Taylor & Francis
Although renal transplantation ameliorates cardiovascular risk factors by restoring renal
function, it introduces new cardiovascular risks including impaired glucose tolerance or …

[HTML][HTML] The 'indirect'effects of cytomegalovirus infection

RB Freeman Jr - American Journal of Transplantation, 2009 - Elsevier
Cytomegalovirus (CMV) remains the most important infection in the immunocompromized
host even in the era of effective therapy. CMV is usually acquired early in life and can be …

[HTML][HTML] Cytomegalovirus-induced immunopathology and its clinical consequences

S Varani, MP Landini - Herpesviridae, 2011 - Springer
Human cytomegalovirus (CMV) is a ubiquitous DNA virus that causes severe disease in
patients with immature or impaired immune systems. During active infection, CMV …

Human cytomegalovirus and kidney transplantation: a clinician's update

K De Keyzer, S Van Laecke, P Peeters… - American journal of …, 2011 - Elsevier
Infection with human cytomegalovirus (CMV) is an important cause of morbidity and mortality
in kidney transplant recipients. CMV disease is diagnosed based on the detection of viral …

Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial

O Witzke, IA Hauser, M Bartels, G Wolf, H Wolters… - …, 2012 - journals.lww.com
Background. Cytomegalovirus (CMV) prevention can be achieved by prophylaxis or
preemptive therapy. We performed a prospective randomized trial to determine whether …

[HTML][HTML] Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation

T Reischig, P Jindra, O Hes, M Švecová… - American Journal of …, 2008 - Elsevier
Both preemptive therapy and universal prophylaxis are used to prevent cytomegalovirus
(CMV) disease after transplantation. Randomized trials comparing both strategies are …